Related Experiment Video
Updated: Feb 19, 2026

09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
16.1K
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up
F Pizzolo1, G Salvagno2, B Caruso3
1Unit of Internal Medicine, Department of Medicine, University of Verona, Verona, Italy.
Journal of Human Hypertension
|November 9, 2017
Summary
A new chemiluminescence immunoassay shows promise for screening primary aldosteronism using the aldosterone to renin ratio (ARR). However, it is less accurate for confirmatory tests like the intravenous saline loading test (ivSLT).
Area of Science:
- Endocrinology
- Clinical Chemistry
- Diagnostic Assays
Background:
- Accurate measurement of aldosterone and renin is crucial for diagnosing primary aldosteronism (PA).
- Existing assays have varying thresholds, complicating diagnosis.
- A new fully automated chemiluminescence (CL) immunoassay offers potential for PA screening.
Purpose of the Study:
- To evaluate the accuracy of the CL immunoassay for PA screening and confirmatory testing.
- To compare CL assay results with radioimmunoassay (RIA) for aldosterone and aldosterone to renin ratio (ARR).
- To assess the CL assay's performance in the intravenous saline loading test (ivSLT).
Main Methods:
- Compared aldosterone and ARR measurements using CL and RIA assays.
- Analyzed data from 102 hypertensive patients at baseline and 85 after ivSLT.
- Used Deming regression to assess agreement between the two methods.
Main Results:
- Excellent correlation between CL and RIA for aldosterone (r=0.922) and ARR (r=0.977) overall.
- Established an equivalent ARR cut-off of 20 pg·ml⁻¹·mU⁻¹·l⁻¹ for the CL assay.
- Weaker correlation for low aldosterone concentrations (r=0.676) and lower concordance (68%) in ivSLT results.
Conclusions:
- The CL immunoassay demonstrates comparable performance to RIA for ARR-based PA screening.
- The CL assay is significantly less accurate than RIA for confirmatory ivSLT in diagnosing autonomous aldosterone secretion.
- Further validation is needed for the CL assay in confirmatory diagnostic settings.

